Georgia Bio Blog

WHO, partners roll out faster COVID tests for poorer nations

September 28, 2020

The World Health Organization announced Monday that it and leading partners have agreed to a plan to roll out 120 million rapid-diagnostic tests for the coronavirus to help lower- and middle-income countries make up ground in a testing gap with richer countries — even if it’s not fully funded yet. At $5 apiece, the antigen-based…

Read More

A layperson’s guide to how — and when — a Covid-19 vaccine could be authorized

September 28, 2020

In a U.S. pandemic response dominated by missteps, the effort to develop vaccines to prevent Covid-19 has so far been a triumph. Vaccines against the coronavirus that causes the disease are now racing through giant clinical trials as a result. It’s a terrible irony, then, that the Trump administration’s statements have resulted in an erosion…

Read More

Global investors must support pharma solidarity and collaboration in the response to Covid-19

September 28, 2020

The prospect of having the first supplies of at least a few effective Covid-19 medicines and vaccines by the end of 2020 is a key driver of recent market optimism. New treatments and vaccines are among the best bets for our societies against the risk of recurring Covid-19 flare-ups and persistent lockdowns into 2021. Yet…

Read More

Wanted in Covid-19 Fight: ‘Superdonors’ of Convalescent Plasma

September 27, 2020

Blood banks and researchers are mobilizing to find recovered Covid-19 patients who have high levels of antibodies and are willing to donate regularly Blood banks and researchers are mobilizing to find recovered Covid-19 patients who could be blood plasma “superdonors,” people who have high levels of antibodies against the disease and are willing to donate…

Read More

Early Covid Treatments Could Be a ‘Bridge’ to Vaccine

September 26, 2020

Monoclonal antibodies that stop the coronavirus from spreading in the body are among promising strategies for averting severe illness from Covid-19 before vaccines arrive, said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. Antibody-based medications, other blood products from recovered patients and antivirals are being investigated as early treatments, Fauci said.…

Read More

House passes sweeping clean energy bill

September 25, 2020

The House on Thursday passed a broad bill that aims to boost energy efficiency and renewable energy sources as part of an attempt to combat climate change.  The chamber approved the 900-page Clean Energy and Jobs Innovation Act in a 220-185 vote.  The legislation would create research and development programs for solar, wind, advanced geothermal…

Read More

Johnson and Johnson vaccine produced strong immune response, early results say

September 25, 2020

There is some good news on Johnson & Johnson’s coronavirus vaccine. Early results from a Phase 1/2a clinical trial show it was well tolerated and even one dose appeared to produce a strong immune response in almost all of the 800 participants. The trial included two age groups: 18- to 55-year-olds and 65 and older,…

Read More

Among people of color asked to join Covid-19 vaccine trials, worries about inequities run deep

September 25, 2020

While presenting the Covid-19 vaccine study she’s running, Susan Little was asked for a promise she didn’t have the power to make. A respected local politician refused to support the trials unless Little could ensure that the people of color being prioritized as volunteers would also be prioritized once an effective vaccine was approved. “They…

Read More

Pharmacies are bracing for a surge in demand for flu shots amid the Covid-19 pandemic

September 25, 2020

With flu season fast approaching, and the Covid-19 pandemic raging on, hospitals and pharmacies across the country are stockpiling far more flu vaccines than normal, anticipating a surge in demand. The drug store chain Rite Aid has purchased 40% more influenza vaccines than other years to meet an expected uptick in demand. Walgreens has also…

Read More